What is the conversion for furosemide (Lasix) from oral (PO) to intravenous (IV) administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

When converting furosemide from oral to intravenous administration, the dose should be at least equivalent to the previous oral dose.

Key Points

  • The initial intravenous dose of furosemide should be at least equal to the pre-existing oral dose used at home 1.
  • For patients with new-onset acute heart failure or those without a history of renal failure and previous use of diuretics, an intravenous bolus of 20-40 mg may be considered 1.
  • In cases where patients are already on chronic oral therapy, the intravenous dose should be at least equivalent to the oral dose 1.
  • It's essential to tailor the intravenous diuretic dose to the type of acute heart failure and the patient's renal function, and to monitor urine output and renal function closely 1.
  • The total furosemide dose should be limited to the smallest amount necessary to provide an adequate clinical effect, and should not exceed 100 mg in the first 6 hours and 240 mg during the first 24 hours 1.

From the FDA Drug Label

Adults: Parenteral therapy with Furosemide Injection should be used only in patients unable to take oral medication or in emergency situations and should be replaced with oral therapy as soon as practical. The usual initial dose of furosemide is 20 to 40 mg given as a single dose, injected intramuscularly or intravenously The dose may be raised by 20 mg and given not sooner than 2 hours after the previous dose until the desired diuretic effect has been obtained

The conversion for furosemide (Lasix) from oral (PO) to intravenous (IV) administration is 1:1. The same dose is used for both oral and intravenous administration, with the intravenous dose given slowly over 1 to 2 minutes. 2

From the Research

Conversion from Oral to Intravenous Administration

The conversion for furosemide (Lasix) from oral (PO) to intravenous (IV) administration can be determined based on the bioavailability of the drug.

  • The mean absolute bioavailability of furosemide was found to be 42.8% and 44.0% as calculated from plasma and urine data, respectively 3.
  • Another study reported a bioavailability of 51% for oral administration of furosemide in healthy subjects 4.
  • A study in elderly patients found a mean bioavailability of 49% with a range of 12-112% 5.

Dosing Considerations

When converting from oral to IV administration, the dose may need to be adjusted based on the bioavailability of the drug.

  • A study compared the efficacy and bioavailability of a 500 mg oral dose to a 250 mg IV dose in peritoneal dialysis patients 6.
  • However, the exact conversion ratio is not explicitly stated in the provided studies.

Pharmacokinetics and Pharmacodynamics

The pharmacokinetics and pharmacodynamics of furosemide can affect its conversion from oral to IV administration.

  • The total plasma clearance of furosemide was found to be 164 +/- 26 ml/min, with a renal clearance of 66.2 +/- 6.8% of the total clearance 3.
  • The volume of distribution at steady state was reported to be 109 +/- 19 ml/kg 3 and 8.3 +/- 0.61 l 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.

Drug metabolism and disposition: the biological fate of chemicals, 1980

Research

Pharmacokinetic and Dynamic of Furosemide in Peritoneal Dialysis Patients.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.